A key goal of whole genome sequencing (WGS) for human genetics studies is to interrogate all forms of variation, including single nucleotide variants (SNV), small insertion/deletion (indel) variants and structural variants (SV).
INTRODUCTION
Human genetics studies employ WGS to enable comprehensive trait mapping analyses across the full diversity of genome variation, including SVs (≥50 bp) such as deletions, duplications, insertions, inversions and other rearrangements. Analyses of SV suggest that such variation plays a disproportionately large role (relative to their abundance) in rare disease biology 1 , and in shaping heritable gene expression differences in the human population [2] [3] [4] . Rare and de novo SVs have been implicated in the genetics of autism [5] [6] [7] [8] and schizophrenia [9] [10] [11] [12] , but few other complex trait association studies have directly assessed SVs 13, 14 . With the advent of WGS, it is now possible to characterize a more diverse collection of SVs and deepen our understanding across a wider range of traits.
One challenge for SV interpretation in WGS-based studies is the relative lack of high-quality publicly available variant maps from large populations. Our current knowledge of SV in human populations is based primarily on three sources: (1) a large and disparate collection of array-based studies, organized in various databases [15] [16] [17] , with limited allele frequency information and technical challenges that limit sensitivity, accuracy and resolution; (2) the 1000 Genomes Project callset derived from 2,504 low-coverage (median 7x) WGS datasets 4 , which has been invaluable but is limited by the modest sample size and low coverage design (which hindered rare variant discovery); and (3) an assortment of smaller WGS-based studies with varied coverage, technologies, analysis methods, and levels of data accessibility, only 4 of which contribute more than 100 unrelated samples (500 Dutch 18 , 100 Danish 19 , 232 globally diverse 20 , and ~519 autism families 7, 8 ).
There is an opportunity to improve knowledge of SV in human populations via systematic analysis of large-scale WGS data resources generated by programs such as the NHGRI Centers for Common Disease Genomics (CCDG). A key barrier to the creation of larger and more informative SV catalogs is the lack of computational tools that can scale to the size of ever growing datasets. To begin to address this need, we have This SV catalog is freely available and will aid variant interpretation in "n-of-one" WGS applications.
RESULTS

A population-scale map of structural variation
The samples analyzed here are derived from common disease case/control and quantitative trait mapping collections sequenced under the CCDG program, supplemented with ancestrally diverse samples from the PAGE consortium (~950 Latinos) and Simons Genome Diversity Panel (263 individuals from 142 populations).
The sample set also includes 1,823 families consisting of two or more first-degree relatives, including a set of multi-generational CEPH pedigrees comprising 595 samples and 80 founders. The samples do not include known rare disease cases. The final ancestry composition is extremely diverse, including 23% African American, 16% Latino, 11% Finnish European, 39% non-Finnish European, 6% unknown, and 6% ancestrally diverse samples from various sites around the world ( Table 1) .
The tools and pipelines used for this work are described in detail elsewhere (https://www.biorxiv.org/content/early/2018/12/13/494203). Briefly, we have developed a highly scalable software toolkit (svtools) and distributed workflow for large-scale SV callset generation that combines per-sample variant discovery (via LUMPY 21 ), resolution-aware cross-sample merging, breakpoint genotyping (via SVTYPER 22 ), copy number annotation, variant classification, and callset refinement ( Fig. 1) . Our pipeline is built on a foundation of well-established tools (LUMPY 21 , SPEEDSEQ 22 , SVTYPER 22 ) that have been extensively tested in prior studies 3, 21, 22 , combined with various new optimizations and an innovative cross-sample merging and genotyping strategy that provides efficient and affordable joint analysis of >100,000 genomes at near-basepair resolution.
We created two distinct SV callsets using different reference genome and pipeline versions. The "B37" callset includes 118,973 high-confidence SVs from 8,417 samples sequenced at the McDonnell Genome Institute, that were aligned and processed using SpeedSeq 22 and the GRCh37 reference genome and analyzed with the LSF-based "B37" SV mapping pipeline. The "B38" callset includes 241,426 high-confidence SVs from 23,239 samples sequenced at four different CCDG sites, that were aligned to GRCh38 using the newlydeveloped "functional equivalence" pipelines 23 , and analyzed on the Google Cloud using the "B38" SV mapping pipeline (see Methods) as part of CCDG "Freeze 1". 5,245 samples are included in both callsets, resulting in a non-redundant total of 26,731 samples. Of these, 17,795 samples are permitted for aggregate-level sharing;
these comprise the official public release (Supplementary Files 1 and 2) and are the basis for all analyses presented below. This dataset contains ~7-fold more individuals than the largest prior WGS-based study of SV 4 .
We release the public B37 (n=8,417) and B38 (n=14,623) callsets separately to enable their use in applications that are sensitive to reference genome and pipeline version effects, although they can be combined (e.g., via liftover) for basic analyses involving unique genomic regions, as below. For simplicity, most analyses below focus on the public version of the B38 callset, although we note that the B37 callset will be extremely useful for the numerous human genetics projects that continue to rely on the GRCh37 reference.
By a variety of measures, both callsets appear to be high quality. We observe a mean of 4,442 highconfidence SVs per genome, predominantly composed of deletions (35%), mobile element insertions (27%), and tandem duplications (11%) ( Fig. 2b, Supplementary Figs. 1 and 2) . Variant counts and linkage disequilibrium patterns ( Supplementary Figs. 1c and 1e) are consistent with prior studies employing similar methods, including the GTEx callset that was characterized extensively in the context of eQTL mapping 3 . We achieve expected variant detection performance for embedded 1KGP samples, consistent with prior studies using similar methods 3,21,22 (https://www.biorxiv.org/content/early/2018/12/13/494203). As expected, the site-frequency spectrum largely mirrors that of SNVs and indels ( Fig. 2c, Supplementary Fig. 1d ), the size distribution shows increasing length with decreasing frequency (which suggests negative selection against larger variants, Fig. 2d ), principal components analysis reveals the expected population structure based on self-reported ancestry ( Supplementary Fig. 3 ), and dosage sensitivity analyses show strong concordance with independent measures of functional constraint and genome function (see Fig. 5 and analysis below). The number and types of highconfidence SVs observed per genome are remarkably consistent across the sample set ( Supplementary Figs.   1 and 2) , with noticeably higher levels of genetic variation in African-ancestry individuals, as expected. Although there is some technical variability in SV numbers due to cohort and sequencing center, the effects are mainly limited to small (<1 kb) deletions and tandem duplications detected solely by read-pair signals, which are sensitive to library preparation and alignment filtering methods that differ among CCDG sites ( Supplementary   Fig. 2a , see Methods). In this respect the B37 callset has superior quality due to the more consistent read-depth and fragment length distribution of WGS data produced at a single center. Finally, and perhaps most importantly,
high-confidence SVs have an acceptably low Mendelian error rate (<5%; see Supplementary Figs. 1c and 2c)
as judged by segregation within 36 nuclear families, and there is a strong relationship between variant quality metrics and error rate ( Supplementary Fig. 2c ), such that the callset can be further tuned for specific applications using available metadata.
Notably, both SV maps have extremely high genomic resolution relative to current resources: 72% of SV breakpoints are mapped to single-base resolution and 80% are mapped within 10 bp ( Fig. 2e) . The high resolution nature of this resource will be extremely valuable for variant interpretation in n-of-one studies, and for developing graph-based SV genotyping methods 24 .
Burden of deleterious rare structural variants
The contribution of rare SV to human disease remains unclear. Well-powered WGS-based trait mapping studies will ultimately be required to address this; however, the overall burden of predicted pathogenic mutations in the human population is informative and can be estimated from our data. To characterize the relative impact of different coding SV classes we calculated two measures of purifying selection ( Fig. 3d) : (1) the fraction of variants that affect dosage tolerant genes with an LoF intolerance (pLI) 25, 26 score <0.9, which reflects depletion of that variant class in more dosage sensitive genes; and (2) the fraction of variants present as ultra-rare "singletons" found in only one individual or family, which reflects the extent to which alleles of a given class are being "flushed" from the population due to their deleterious effects (under the assumptions outlined below). Deletions are more deleterious than duplications, complete gene deletions are the most deleterious class, and sub-genic deletions affecting ≥20% of exons approach similar levels as whole gene deletions. Notably, based on the fraction of variants in dosage tolerant genes, complete gene duplications and sub-genic deletions affecting <20% of exons show surprisingly strong levels of deleteriousness. This suggests that most gene-altering SVs are strongly deleterious, even if not predicted to completely obliterate gene function, and that the upper range of our 4.0-11.2% estimate may be more accurate.
The above calculations ignore deleterious missense and non-coding variants that are expected to comprise a large fraction of rare functional variation. Predicting the impact of these variant types is challenging; however, it should be possible to approximate their proportional contribution to the deleterious variant burden under two simplifying assumptions: (1) impact prediction algorithms such as CADD 27 and LINSIGHT 28 are capable of ranking variants within a given class (SNV, indel, SV) by their degree of deleteriousness, and (2) the mean deleteriousness of a given subset of variants is reflected by its singleton rate. The first assumption is somewhat tenuous, but should be valid for this analysis considering that impact prediction inaccuracies are likely to affect variant classes similarly given use of the same underlying models (CADD and LINSIGHT). The second assumption should hold true under an infinite sites model of mutation, which seems reasonable at the sample size used for this analysis (n=4,298). We note that other evolutionary forces such as positive selection, background selection, and biased gene conversion can also shape the site frequency spectrum; however, it seems likely that these forces would act similarly on the variant classes examined here, in a genome-wide analysis of a very large number of sites.
Thus, to compare levels of deleterious SVs relative to SNVs and indels, we can select impact score thresholds separately to yield the same singleton rate for each class. We used CADD and LINSIGHT to generate combined impact scores for SNVs, indels, deletions and duplications (see Methods), where SVs are scored using a scheme that aggregates per-based CADD/LINSIGHT scores across the affected genomic region (as in SVScore 29 ). As expected, these scores are highly correlated with singleton rate and with variant effect predictions from VEP 30 and LOFTEE 25 (Fig. 4a-c) . We sought to identify variants from each class (SNV, indel, DEL, and DUP) with deleteriousness equivalent to high-confidence LoF mutations defined by VEP and LOFTEE, by using an impact score threshold that yields a singleton rate matching that of the entire set of high-confidence LoF mutations (hereafter referred to as "strongly deleterious" variants). Individuals carried a mean of 121.9 such "strongly deleterious" rare variants, comprising 63% SNVs, 19.8% indels and 17.2% SVs (96.9% of which are deletions) ( Fig. 4d) . Taking into account the relative numerical abundance of different rare variant classes, this suggests that a given rare SV is 841-fold more likely to be strongly deleterious than a rare SNV, and 341-fold more likely than a rare indel. Predicted deleterious SVs are slightly larger than rare SVs on the whole (median 4.5 vs. 2.8 kb). Whereas only a minority (13.1%) of predicted strongly deleterious SNVs and indels are noncoding, 90.1% of predicted strongly deleterious rare SVs are non-coding. Remarkably, the top 50% of non-coding deletions show similar levels of purifying selection (as measured by singleton rate) as high-confidence LoFs caused by SNVs/indels (see Fig. 4c ), implying that a typical individual carries 19.1 strongly deleterious rare noncoding deletion alleles. This suggests that non-coding deletions have surprisingly strong deleterious effects and may play a larger than expected role in human disease.
These results demonstrate that SVs comprise a significant fraction of the burden of rare deleterious variants in the human population, to an extent that greatly exceeds their numerical contribution to genome variation overall, and that comprehensive ascertainment of SVs will improve trait association power in both common and rare disease studies.
Landscape of ultra-rare structural variation
Most ultra-rare SVs represent recent or de novo structural mutations, and thus the relative abundance of different ultra-rare SV classes sheds light on the underlying mutational processes at work. We identified 158,991 ultrarare SVs (105,175 high-confidence) that were present in only one of the 14,623 individuals included in the B38 callset, or that were private to a single family (MAF<0.01%). This corresponds to a mean number of ~11.4 per individual, with a relatively uniform distribution across individuals ( Supplementary Fig. 4a ). Ultra-rare SVs are mainly composed of deletions (5.2 per person) and duplications (1.3), with a smaller number of inversions (0.17).
Interestingly, ~40% of ultra-rare SV breakpoints in our dataset cannot be readily classified into the canonical forms of SV. This is a known limitation of short-read WGS, and often such variants are ignored.
Formally, as per the VCF specification 31 , these SVs are of the generic "breakend" (BND) variant class used to denote SVs whose true structure is unknown. We examined the 63,559 ultra-rare BNDs for insights into their composition and origin. Many (17.0%) appear to be deletions that are simply too small (<100 bp) to exhibit convincing read-depth support, and that our pipeline conservatively classifies as BNDs rather than assuming DNA has been lost (e.g., complex SVs can masquerade as deletions). 2.4% of the ultra-rare BNDs stem from 1,542 "retrogene insertions" caused by retroelement machinery acting on mRNAs. This map of retrogene insertions (also known as "retrocopies" or "retroduplications") is ~10-fold larger than prior maps 32-34 and will be valuable for future studies of this phenomenon. 5.5% of ultra-rare BNDs appear to be complex genomic rearrangements with multiple breakpoints in close proximity (<100 kb). The remainder are difficult-to-classify variants involving either local (49.9% ≤1 Mb), distant intra-chromosomal (5.7% >1 Mb), or inter-chromosomal alterations (27.2%), many (78.0%) of which are classified as low-confidence SV calls. This final class is likely caused primarily by repetitive element variation, but should be interpreted with caution since we also expect them to be enriched for false positives.
A variety of sporadic disorders are caused by extremely large and/or complex SVs, but the frequency of these dramatic alterations in the general population is not well understood. These include megabase-scale CNVs, translocations, and complex genomic rearrangements involving multiple distant loci. We observed 47 extremely large (>1 Mb) deletions and 91 extremely large duplications, corresponding to a frequency of ~0.01 per individual, which affect a mean of 12.1 genes ( Supplementary Fig. 4b ). Three individuals carried two megabase-scale CNVs, apparently due to independent mutations. We observed 19 reciprocal translocations, corresponding to a frequency of 0.001 per individual, consistent with (albeit somewhat lower than) prior cytogenetic-based estimates 35, 36 . Of these translocations, 14 affect a gene at one breakpoint and 2 affect a gene at both breakpoints, producing 1 predicted in-frame gene fusions (PI4KA:MGLL). We next applied breakpoint clustering approaches (as in 37 ) to identify ultra-rare complex rearrangements involving 3 or more breakpoints and discovered 33 complex SVs spanning >1 Mb, representing a frequency of 0.003 per individual. Most megabase-scale complex SVs (20/33, 60.6%) appear to involve three breakpoints; however, we observed 5 large-scale rearrangements with 5 or more breakpoints. Notably, when the entire SV size distribution is considered, 3.3% of ultra-rare SVs are complex variants based on the presence of multiple adjacent breakpoints in the same individual, consistent with previous smaller-scale studies [38] [39] [40] [41] [42] .
Dosage sensitivity of genes and noncoding elements
A motivation for creating population-scale SV maps is to annotate genomic regions based on their tolerance to dosage changes and structural rearrangements. These annotations can reveal the genes and non-coding elements that are most important (or dispensable) for human development and viability, and thus help interpret rare variants in n-of-one studies. The pLI score from ExAC/gnomAD 25, 26 has proven invaluable for this purpose and is based on more samples than analyzed here; however, pLI does not measure the effects of increased dosage, or include non-coding elements. Other CNV-based dosage tolerance maps are based on microarray 43 or exome sequencing data 44 , and thus have poor resolution and coverage of non-coding regions.
The analyses presented here focus on a non-redundant union of the two callsets including 17,795
samples. We first generated DEL and DUP "sensitivity" scores for each gene based on the frequency of CNVs observed in our callsets, following the general approach of Ruderfer et al. 44 to pLI, which was generated using SNVs and indels from ExAC, and thus uses an independent set of variants.
A combined score from multiple datasets performs better than any single score, and will be useful for interpreting rare SVs (Supplementary File 3) .
We next performed a genome-wide analysis by measuring the frequency of dosage alterations in 1 kb sliding windows across the entire genome (see Methods). Based on the density of CNVs, our current dataset is not large enough to predict dosage sensitive non-coding elements based on the absence of variation; however, we can investigate the relative sensitivity of different genomic features, in aggregate. As expected, genic regions are highly depleted for dosage alterations in a manner that correlates with gene pLI (Fig. 5a) . In fact, dosage sensitive genes confound analysis of non-coding elements since they cast "shadows" that extend into neighboring regions. Indeed, we observe a strong depletion of CNV near coding exons that varies depending on the proximity to the nearest exon as well as pLI of the corresponding gene ( Fig. 5a) . We therefore estimated odds ratios for depletion of CNV in each functionally annotated region, stratified by binned distance and pLI of the nearest exons, using a Cochran-Mantel-Haenszel estimator. Because adjacent windows are not strictly independent observations -i.e., CNV or features may overlap adjacent windows and induce spatial correlations -we used a blocked bootstrap resampling procedure to estimate robust confidence intervals. The resulting dosage sensitivity scores strongly correlate with independent measures of selective constraint including LINSIGHT and PHASTCONS ( Fig. 5b) .
We examined the relative dosage sensitivity of regulatory and epigenomic annotations from various projects [45] [46] [47] [48] [49] [50] (Figs. 5c and 5d ). Regulatory elements such as enhancers, polycomb repressors, CTCF sites, DNase hypersensitivity sites, and transcription factor binding sites show strong sensitivity to dosage loss via deletion, whereas inert non-coding annotations such as quiescent and heterochromatic regions do not. The patterns of sensitivity to dosage gains via duplication are broadly similar across annotation classes, albeit weaker. This suggests that, as for genes 44 (Fig. 5a) , dosage sensitivity of non-coding elements is generally consistent with regards to losses versus gains, and does not show obviously distinct patterns at (for example) enhancers, repressors or insulators. Dosage sensitivity of regulatory elements at "bivalent" genomic regions from ROADMAP is greater than their typical counterparts (e.g., enhancers vs. bivalent enhancers in Fig. 5d ),
suggesting that such elements are under especially strong selection. Interestingly, when we consider the full set of ROADMAP annotations across all 127 cell-types, dosage sensitivity increases gradually as a function of the number of cell-types sharing an annotation at that genomic interval. This suggests that constitutive regulatory elements are more sensitive to dosage changes than those that act in a more cell-type specific manner.
The above analyses offer a first glimpse at the types of SV-based genome annotation efforts that will be possible with increased sample sizes expected to be available in the near future.
DISCUSSION
Here, we have conducted the largest-scale WGS-based study of SV in the human population to date. Perhaps most notably, the large sample size and use of deep WGS allowed us to map a very large number of rare SVs at very high genomic resolution -typically resolved to a single base -and estimate the burden of deleterious SV relative to other variant classes, which has not been possible in prior studies. Our data suggest that rare SVs account for 4.0-11.2% of deleterious coding alleles and 17.2% of deleterious alleles genome-wide, which is a remarkably large and outsized contribution considering that SVs comprise merely ~0.1% of variants. Especially noteworthy is the surprisingly large burden of rare, strongly deleterious non-coding deletions apparent in our dataset: we estimate that the typical individual carries ~19 rare non-coding deletions that exhibit levels of purifying selection similar to those for high-confidence LoF variants caused by SNVs or indels (of which there are ~34 per individual). Thus, a relatively large number of rare non-coding deletions with strong adverse fitness effects exist in the human population, and it seems reasonable to expect that these make a proportionally large contribution to human disease. These results argue that comprehensive assessment of coding and non-coding SVs will significantly improve trait-mapping power in human genetics studies.
This study has also created valuable community resources. The SVs site-frequency maps that we have generated and publicly released will enable improved SV interpretation efforts. Indeed, there is immense value to having publicly available site-frequency maps from large populations of individuals, generated systematically from modern sequencing platforms and deep data (≥20x), using open source tools and pipelines that are available to the research community (as exemplified by the impact of ExAC/gnomAD 25, 26 Meade, MD, Saunak Sen, PhD and Fred Lurmann, MS. The authors also wish to thank the staff and participants who contributed to the GALA II study.
METHODS
Generation of the "Build 38" (B38) callset
Per-sample processing. This callset is derived from 23,559 individuals that were part of the CCDG program as well as 950 Latino samples from the PAGE consortium. All data was produced at one of the four CCDG-funded sequencing centers and aligned to genome build GRCh38 using each individual center's functionally equivalent pipeline implementation 23 . Per-sample calling was performed on 23,547 samples using LUMPY 21 Per-sample QC. We observed an excess of small (400 -1000 bp) singleton deletions (i.e., present in only a single sample), suggesting a large number of false positives. On further investigation, this excess arose from differences between centers in library insert-size distribution. To reduce the number of false positive small deletions, deletions of ≤1000 bp were eliminated unless they had split read support in at least one sample.
Subsequently, per-sample quality control was performed to eliminate outlier samples. We removed 213 samples where variant counts (for any SV type) were >6 median absolute deviations from the median count for that type.
Merging and cohort-level re-genotyping. removed. In addition, we removed samples with genotype missingness >2% . These QC filters removed a total of 120 additional samples. Finally, we removed 64 samples that were identified as duplicates or twins in a larger set of data.
Breakpoint resolution
Breakpoint resolution was calculated using bcftools (v1.3.1) query to create a table of confidence intervals for each variant in the callset, but excluding secondary BNDs. Each breakpoint contains two 95% confidence intervals, one each around the start location and end location. For each breakpoint, the resolution was defined as the average width of these two intervals. Summary statistics were calculated in RStudio (v1.0.143; R version 3.3.3).
Self-reported ethnicity
Self-reported ethnicity was provided for each sample via the sequencing center and aggregated by the NHGRI Genome Sequencing Program (GSP) coordinating center. For each combination of reported ethnicity and ancestry, we assigned a super-population, continent (based on the cohort), and ethnicity. Samples where ancestry was unknown, but the sample was Hispanic, were assigned to the Americas (AMR) superpopulation.
Summarized data are presented in Table 1 .
Sample relatedness
As SNV calls were not yet available for all samples at the time of the analysis, relatedness was estimated using large (>1 kb), high-quality autosomal deletions and mobile element insertions with allele frequency >1%. These were converted to plink format using plink (v1.90b3.38) and then subjected to kinship calculation using KING 53 (v2.0). The resulting output was parsed to build groups of samples connected through first degree relationships (kinship coefficient > 0.177). Each group was assigned an arbitrary family identifier. Correctness was verified by the successful recapitulation of the 36 complete Coriell trios included as variant calling controls.
Callset summary metrics
Callset summary metrics were calculated by parsing the VCF files with bcftools (v1.3.1) query to create tables containing information for each variant/sample pairing or variant alone, depending on the metric. Breakdowns of the BND class of variation were performed using vawk to calculate orientation classes and sizes. These were summarized using Perl and then transformed and plotted using RStudio (v1.0.143; R version 3.3.3).
Ultra-rare variant analysis
We defined an ultra-rare variant as any variant unique to one individual or one family of first degree relatives.
We expect the false positive rate of ultra-rare variants to be low because systematic false positives due to alignment issues are likely to be observed in multiple unrelated individuals. Therefore, we considered both high and low confidence variants in all ultra-rare analyses.
Constructing variant chains.
Complex variants were identified as in Chiang et al. 3 by converting each ultra-rare SV to BED format and, within a given family, clustering breakpoints occurring within 100,000 bp of each other using bedtools 54 Manual review. Manual review of variants was performed using IGV (v2.4.0). Variants were converted to BED12 using svtools (v0.3.2) for display within IGV. For each sample, we generated copy number profiles using CNVnator (v0.3.3) in 100 bp windows across all regions contained in the variant chains.
Retrogene insertions. Retrogene insertions were identified by examining the ultra-rare variant chains constructed as described above. For each chain, we identified any constituent SV with a reciprocal overlap of 90% to an intron using bedtools (v2.23.0). For each variant chain, the chain was deemed a retrogene insertion if it contained one or more BND variants with +/-strand orientation that overlapped an intron. Additionally, we flagged any chains that contained non-BND SV calls, as their presence was indicative of a potential misclassification, and manually inspected them to determine if they represented a true retrogene insertion.
Complex variants. We retained any cluster(s) incorporating 3 or more SV breakpoint calls, but removed SVs identified as retrogene insertions either during manual review or algorithmically. In addition, we excluded one call deemed to be a large, simple variant after manual review.
Large variants. Ultra-rare variants >1 Mb in length were selected and any overlap with identified complex variants identified and manually reviewed. Of 5 potential complex variants, one was judged to be a simple variant and included as a simple variant while the rest were clearly complex variants and excluded. Gene overlap was determined as an overlap ≥1 bp with any exon occurring within protein-coding transcripts from Gencode v27 marked as a principal isoform according to APPRIS 55 .
Balanced Translocations. Ultra-rare generic "breakend" (BND) variants, of any confidence class, connecting two chromosomes and with support (>10%) from both strand orientations were initially considered as candidate translocations. We further filtered these candidates to require exactly two reported strand To determine if a translocation resulted in an in-frame fusion, we converted to BEDPE, padded by 1 bp and intersected the breakpoints with all introns using bedtools (v2.23.0). Each intron entry was then padded by 1 bp and intersected with the Gencode GTF file using bedtools (v2.23.0) and restricting to coding exons of the same transcript as the intron. Then, for each set of exons intersected by a given translocation, all combinations of transcripts were compared, taking into account their orientation and the orientation of the breakpoint, to determine if frame was maintained across the potentially fused exons. Merging. The remaining samples were processed into a single, joint callset using svtools (v0.3.2) and the two-stage merging workflow (as described above): each of the 9 cohorts was sorted and merged separately in the first stage, and the merged calls from each cohort sorted and merged together in the second stage. 
Annotation of gene-altering SV calls
The VCF was converted to BEDPE format using svtools vcftobedpe The resulting BEDPE file was intersected 
Gene-based estimation of dosage sensitivity
We followed the method of Ruderfer et al. 44 , to estimate genic dosage sensitivity scores using counts of exonaltering deletions and duplications in a combined callset comprising the 14,623 sample pan-CCDG callset plus 3,172 non-redundant samples from the B37 callset. Build37 CNV calls were lifted over to build38 as BED intervals using crossmap (v0.2.1) 59 . We determined the counts of deletions and duplications intersecting coding exons of principal transcripts of any autosomal gene. In Ruderfer et al. 44 , the expected number of CNVs per gene was modeled as a function of several genomic features (GC content, mean read depth, etc.), some of which were relevant to their exome read-depth CNV callset but not to our WGS-based breakpoint mapping lumpy/svtools callset. In order to select the relevant features for prediction, we restricted to the set of genes in which fewer than 1% of samples carried an exon-altering CNV, and used l 1 -regularized logistic regression (from the R glmnet package 60 , v2.0-13), with the penalty l chosen by 10-fold cross-validation. The selected parameters (gene length, number of targets, and segmental duplications) were then used as covariates in a logistic regression-based calculation of per-gene intolerance to DEL and DUP, similar to that described in Ruderfer et al. 44 . For deletions (or duplications, respectively), we restricted to the set of genes with <1% of samples carrying a DEL, to estimate the parameters of the logistic model. We then applied the fitted model to the full set of genes to calculate genic CNV intolerance scores as the residuals of the logistic regression of CNV frequency on the genomic features, standardized as z-scores and with winsorization of the lower 5 th percentile.
Genome-wide estimation of deleterious variants
In order to estimate the relative numbers of deleterious SNV, indels, DELs and DUPs genome-wide in the normal population, we relied on a subset of 4,298 samples from the B38 callset for which we had joint variant callsets for both SNVs/indels (GATK) and SVs (lumpy/svtools). Each SNV and indel was annotated with CADD 27 and LINSIGHT 28 scores as described above. CADD and LINSIGHT scores were converted to percentiles and singleton rates calculated for variants above each score threshold. CADD and LINSIGHT scores were then calibrated to a standard scale by matching singleton rates. Each DEL and DUP was annotated with CADD and LINSIGHT scores, calculated as the mean of the top 10 single-base CADD or LINSIGHT scores, respectively, for the span of the CNV (as implemented in SVSCORE 29 ). The CNV-level CADD and LINSIGHT scores were then standardized using the above calibration curves. Finally, each variant (SNV, indel, or CNV) was assigned a combined CADD-LINSIGHT score, calculated as the maximum of the 2 distinct scores.
The combined scores provided a means to rank, within each variant class, variants in order of deleteriousness. We calculated a singleton rate for the set of all LOFTEE high confidence protein-truncating SNV and indels in highly-conserved (top 10% of pLI) autosomal genes. We then estimated the number of deleterious variants of each type genome-wide by choosing the combined CADD-LINSIGHT score threshold as the minimum value such that the singleton rate for the set of higher-scoring variants was greater than or equal to the singleton-rate for LOFTEE high-confidence PTVs.
Annotation of non-coding elements
We divided the genome into 1 kb non-overlapping windows to investigate the rates of CNV occurrence relative to various classes of coding and non-coding elements, genome-wide. Windows intersecting assembly gaps or high-copy number outlier regions (as described above) and windows with fewer than 50% of bases uniquely mappable as determined using GEM-mappability (build 1.315) 61 were excluded from analysis. Bed tracks of genomic annotations for the non-coding dosage sensitivity analysis were created as described below.
The phastcons-20way 62 conservation track was downloaded from the UCSC genome browser (rsync://hgdownload.cse.ucsc.edu/goldenPath/hg38/phastCons20way/hg38.phastCons20way.wigFix.gz) and
converted to bed format. The mean phastcons score for each 1 kb window was calculated using bedtools map.
Quantiles of mean window-level phastcons scores were calculated and used as thresholds for the sensitivity analysis. Chromatin interaction domains derived from Hi-C on hESC and IMR90 cells 68 were downloaded from http://compbio.med.harvard.edu/modencode/webpage/hic/, and distances between adjacent topological domains calculated with bedtools. When the physical distance between adjacent topological domains was <400 kb, these were classified as TAD boundaries; otherwise, they were classified as unorganized chromatin. The TAD boundaries and unorganized chromatin data were converted to bed format and lifted over to GRCh38 using crossmap.
Roadmap chromatin state segmentations for 127 epigenomes were downloaded from Roadmap 46 (https://egg2.wustl.edu/roadmap/data/byFileType/chromhmmSegmentations/ChmmModels/coreMarks/jointMod el/final/) and lifted over to GRCh38. Bedtools multiinter was used to determine the number of epigenomes in which each segment was present.
Dosage sensitivity of non-coding elements
To maximize power, DEL and DUP calls from the non-redundant union of the B37 and B38 callsets (as described above) were used for this analysis. Each window was further characterized by its distance to the nearest exon (the minimum distance between any point in the window and any point in the exon) and the pLI score of the gene corresponding to the nearest exon. The pLI score was set to zero for genes with pLI undefined. In the event that exons of 2 genes were equidistant to the window, the max of the two pLI scores was selected.
For a given SV type (DUP or DEL) and a given functional annotation (e.g., VISTA enhancers), each window was characterized by the presence or absence of one or more SV and the presence or absence of one of more genomic features. We observed a depletion of CNV in windows near exons, and in particular near exons of LoF-intolerant genes (see Fig. 5a ). As such, we used a Cochran-Mantel-Haenszel test to estimate the odds ratios for each SV type/functional annotation, while stratifying for the proximity to the nearest exon as well as that exon's LOF-intolerance (pLI). Because adjacent windows are not strictly independent observations -i.e., CNV or features may overlap adjacent windows inducing some spatial correlations -we used a block bootstrap method (resampling was performed on non-overlapping blocks of 10 windows) to estimate robust confidence intervals.
Predictor Common  DEL  72,595  33,111  2,522  4,100  MEI  227  842  251  2,001  DUP  17,822  9,613  434  1,093  INV  576  378  36  52  Low-confidence INV  4,212  9,824  828  1,482  BND  13,955  18,306  772  1,621  Low-confidence BND  49,604  156,035  27, Figure 3 . Principal components analysis for the B37 callset. PCA were calculated using an LDpruned subset of high-confidence DEL and MEI variants, with MAF>1%. Ancestry is based on self-report, using the color scheme at right, using the ancestry abbreviations described in Table 1 . 
